🚀 VC round data is live in beta, check it out!
Lipum Valuation Multiples
Discover revenue and EBITDA valuation multiples for Lipum and similar public comparables like Outlook Therapeutics, Marinomed Biotech, Longeveron, BioXcel Therapeutics and more.
Lipum Overview
About Lipum
Lipum AB is a clinical-stage biopharmaceutical company specializing in the discovery and development of a novel treatment for chronic inflammatory diseases. The candidate SOL-116 is a humanized antibody designed to provide efficacious therapy by blocking a previously overlooked target molecule (BSSL) of the immune system. The development is supported by solid pre-clinical data for rheumatoid arthritis. Lipum also explores other inflammatory diseases with a high unmet medical need.
Founded
2010
HQ
Employees
5
Website
Sectors
Financials (FY)
EV
$32M
Lipum Stock Performance
Lipum has current market cap of $32M, and enterprise value of $32M.
Market Cap Evolution
Lipum's stock price is $1.52.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $32M | $32M | 0.0% | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLipum Valuation Multiples
Lipum Financial Valuation Multiples
As of April 18, 2026, Lipum has market cap of $32M and EV of $32M.
Equity research analysts estimate Lipum's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $32M | XXX | $32M | XXX | XXX | XXX |
| EV (current) | $32M | XXX | $32M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Lipum Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Lipum Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Lipum | XXX | XXX | XXX | XXX | XXX | XXX |
| Outlook Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Marinomed Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| Longeveron | XXX | XXX | XXX | XXX | XXX | XXX |
| BioXcel Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Tvardi Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Lipum M&A Activity
Lipum acquired XXX companies to date.
Last acquisition by Lipum was on XXXXXXXX, XXXXX. Lipum acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Lipum
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLipum Investment Activity
Lipum invested in XXX companies to date.
Lipum made its latest investment on XXXXXXXX, XXXXX. Lipum invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Lipum
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Lipum
| When was Lipum founded? | Lipum was founded in 2010. |
| Where is Lipum headquartered? | Lipum is headquartered in Sweden. |
| How many employees does Lipum have? | As of today, Lipum has over 5 employees. |
| Is Lipum publicly listed? | Yes, Lipum is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Lipum? | Lipum trades under LIPUM TO1 ticker. |
| When did Lipum go public? | Lipum went public in 2021. |
| Who are competitors of Lipum? | Lipum main competitors are Outlook Therapeutics, Marinomed Biotech, Longeveron, BioXcel Therapeutics. |
| What is the current market cap of Lipum? | Lipum's current market cap is $32M. |
| Is Lipum profitable? | No, Lipum is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.